CIK 0001711754
- Non-accelerated filer
- Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 475205835
- Phone
- +1 858-964-3720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- 4 Open-market buy President & CEO bought 2,000 shares at an average $5.99 ($11,987)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President & CEO bought 2,000 shares at an average $7.03 ($14,058)
- 4 Open-market buy 10% owner bought 10,000 shares at $6.00 ($60,000)
- 4 Open-market buy Director bought 10,000 shares at $6.00 ($60,000)
- 4 Open-market buy CFO, Treasurer & Secretary bought 10,000 shares at $6.00 ($60,000)
- 4 Open-market buy President & CEO bought 10,000 shares at $6.00 ($60,000)
- 4/A Open-market buy President & CEO bought 11,100 shares at $10.75 ($119,325)
- 4/A Open-market buy CFO, Treasurer & Secretary bought 5,000 shares at $10.71 ($53,550)
- 4 Open-market buy 10% owner bought 61,667 shares at $9.00 ($555,003)
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy President & CEO bought 11,100 shares at $9.00 ($99,900)
- 4 Open-market buy CFO, Treasurer & Secretary bought 5,000 shares at $9.00 ($45,000)
- 4 Open-market buy Chairman bought 11,100 shares at $9.90 ($109,890)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 7 of 8 · 142 filings